254 200

Full metadata record

DC FieldValueLanguage
dc.contributor.author윤채옥-
dc.date.accessioned2019-12-09T21:02:11Z-
dc.date.available2019-12-09T21:02:11Z-
dc.date.issued2018-11-
dc.identifier.citationFRONTIERS IN ONCOLOGY, v. 8, Article no. 552en_US
dc.identifier.issn2234-943X-
dc.identifier.urihttps://www.frontiersin.org/articles/10.3389/fonc.2018.00552/full-
dc.identifier.urihttps://repository.hanyang.ac.kr/handle/20.500.11754/120512-
dc.description.abstractWe had previously reported anticancer activity in the water extract (WEX) of Ashwagandha leaves, and identified Triethylene glycol (TEG) as an active tumor suppressor component. In this study, we investigated anti-migratory and anti-angiogenesis activities of WEX and TEG. We conducted in vitro and in vivo experiments using TEG, and its two derivatives, Triethyleneglycol dimethacrylate (TD-10), and Tetraethyleneglycol dimethacrylate (TD-11). The data revealed strong anticancer and anti-metastasis potentials in the derivatives. Non-toxic, anti-migratory doses of the derivatives showed inhibition of canonical Wnt/beta-catenin axis and consequent downregulation of EMT-signaling proteins (Vimentin, MMPs and VEGF). These results endorse that the TD-10 and TD-11 have potential to safely put a check on the aggressiveness of the metastatic cells and therefore represent promising candidates for the treatment of metastatic cancers.en_US
dc.description.sponsorshipThis work was supported by grants from the National Institute of Advanced Industrial Science & Technology (AIST)-DAILAB Special Fund (to SK and RW) and National Research Foundation of Korea (2016M3A9B5942352 and KDDF-201611-05 to C-OY).en_US
dc.language.isoen_USen_US
dc.publisherFRONTIERS MEDIA SAen_US
dc.subjectAshwagandhaen_US
dc.subjectTEGen_US
dc.subjectTEG-derivativesen_US
dc.subjectcell migrationen_US
dc.subjectinvasionen_US
dc.subjectmetastasisen_US
dc.subjecttherapyen_US
dc.titleIdentification and Functional Characterization of Anti-metastasis and Anti-angiogenic Activities of Triethylene Glycol Derivativesen_US
dc.typeArticleen_US
dc.relation.volume8-
dc.identifier.doi10.3389/fonc.2018.00552-
dc.relation.page552-563-
dc.relation.journalFRONTIERS IN ONCOLOGY-
dc.contributor.googleauthorOh, Eonju-
dc.contributor.googleauthorGarg, Sukant-
dc.contributor.googleauthorLiu, Ye-
dc.contributor.googleauthorAfzal, Sajal-
dc.contributor.googleauthorGao, Ran-
dc.contributor.googleauthorYun, Chae-Ok-
dc.contributor.googleauthorKaul, Sunil C.-
dc.contributor.googleauthorWadhwa, Renu-
dc.relation.code2018011076-
dc.sector.campusS-
dc.sector.daehakCOLLEGE OF ENGINEERING[S]-
dc.sector.departmentDEPARTMENT OF BIOENGINEERING-
dc.identifier.pidchaeok-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE